Navigation Links
Specific blood-derived cells promote survival in heart attack model
Date:6/16/2010

Tampa, Fla. (June 16, 2010) A research team from McGill University (Canada) report a beneficial effect on cardiac function in mouse models when implanted monocytes - a type of white blood cell that is part of the immune system - helped preserve cardiac function following a heart attack (myocardial infarction).

Their study, published in the current issue of Cell Transplantation (19:4), is now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/.

With heart failure a leading cause of morbidity and mortality, improving post-myocardial infarction therapies through natural adaptive responses, such as finding ways to boost and use the immune system, is an important area of research.

Monocytes, produced in the bone marrow, circulate in the bloodstream for a few days before moving to tissues throughout the body and play a role in attacking foreign substances in the body, including infection.

New blood vessel growth (angiogenesis) could play an important role in the repair of damaged heart tissue. The researchers therefore chose to grow (culture) monocytes, derived from mouse blood, under angiogenic conditions prior to transplantation to determine if these so-called monocyte derivatives could be beneficial.

"Our purpose was to assess the effect of monocyte derivatives (MDs) on cardiac and endothelial cell proliferation and survival," said the study's lead author Dr. Jacques Galipeau, associate professor of medicine at McGill University's Lady Davis Institute for Medical Research. "In this study, we demonstrated that myocardial protection following infarction can be induced in part by growth factors released by MDs. This finding strongly suggests that these released proteins reduce cardiac cell apoptosis and enhance endothelial cell proliferation in vitro, and reduce fibrosis in vivo."

The McGill researchers found that when they transplanted the MDs into animal models of myocardial infarction, the cells secreted high levels of a variety of growth factors that provided anti-inflammatory properties and also played a role in protecting cells of the heart tissues (cardiomyocytes) from programmed cell death (apoptosis).

The researchers also noted that the majority of MDs did not survive more than two weeks in vitro, suggesting that the cells have an effect shortly after injection.

"Dr. Galipeau's group have clearly demonstrated a beneficial effect of the MDs on myocardial improvement in the post-myocardial infarction remodeling process," said Amit N. Patel, director of cardiovascular regenerative medicine at the University of Utah and section editor for Cell Transplantation." These results further demonstrate the benefits of bone marrow derived cells for cardiac cell therapy."


'/>"/>

Contact: David Eve
celltransplantation@gmail.com
Cell Transplantation Center of Excellence for Aging and Brain Repair
Source:Eurekalert

Related biology news :

1. Specific brain protein required for nerve cell connections to form and function
2. St. Jude identifies the specific cell that causes eye cancer, disproving long-held theory
3. Foods, not specific nutrients, may be key to good health
4. The key to unlocking the secret of highly specific DNAzyme catalysis
5. First-ever study to link increased mortality specifically to carbon dioxide emissions
6. Its a unisex brain with specific signals that trigger male behavior
7. Oocyte-specific gene mutations cause premature ovarian failure
8. New paradigm for cell-specific gene delivery
9. Carnegie Mellon MRI technology that non-invasively locates, quantifies specific cells in the body
10. Researchers seeking to identify Alzheimers risk focus on specific blood biomarker
11. Study reveals specific gene in adolescent men with delinquent peers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2017)...   Bridge Patient Portal , an enterprise ... EMR Systems , an electronic medical record solutions ... established a partnership to build an interface between ... Centricity™ products, including Centricity Practice Solution (CPS), Centricity ... new integrations will allow healthcare delivery networks using ...
(Date:4/17/2017)... 17, 2017 NXT-ID, Inc. (NASDAQ: NXTD ... filing of its 2016 Annual Report on Form 10-K on Thursday ... ... available in the Investor Relations section of the Company,s website at ... website at http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... No two people are believed to ... York University Tandon School of Engineering and Michigan ... partial similarities between prints are common enough that ... and other electronic devices can be more vulnerable ... in the fact that fingerprint-based authentication systems feature ...
Breaking Biology News(10 mins):
(Date:5/24/2017)... (PRWEB) , ... May 24, 2017 , ... ... selection and implementation of CLEARAS Water Recovery’s Advanced Biological Nutrient Recovery (ABNR™) technology ... component of a $24 million plant upgrade to sustainably meet current and future ...
(Date:5/24/2017)... Ebola resurfaces in the Democratic Republic of Congo ... reported, a new analysis of the Ebola gene polymerase Replikin ... 2014 and 2017 outbreaks of the disease.  ... the 2014 outbreak. An analysis of the latest data showed ... which again precedes the current outbreak in the DRC. Sequence ...
(Date:5/23/2017)... ... May 23, 2017 , ... Genedata, ... 20th anniversary, marking the occasion with a strong presence at Bio-IT World Conference ... and further extends an invitation to all attendees to view posters on ...
(Date:5/23/2017)... ... May 23, 2017 , ... Energetiq Technology, a world leader ... expansion to accommodate its rapid growth. , The renovations at the company’s headquarters ... the existing areas. The expansion includes, a state-of-the-art engineering facility, and a second ...
Breaking Biology Technology: